期刊
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY
卷 9, 期 2, 页码 177-189出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/17474124.2014.945914
关键词
6-mercaptopurine; azathioprine; Crohn's disease; inflammatory bowel disease; methotrexate; therapy; ulcerative colitis
Immune modulating drugs such as thiopurines (azathioprine and 6-mercaptopurine) and methotrexate has been a mainstay for treatment of inflammatory bowel disease (IBD) for decades. However, despite widely used in IBD, questions still remain concerning the most rational treatment regimens of these agents. Results from a range of recent studies necessitate increased awareness on how to best use these potent drugs in the clinic. As controversy still remains regarding the most appropriate use of immunomodulators, this review is based on scrutinizing the current literature, with emphasis on randomized controlled trials and Cochrane reviews, focusing on aspects that can lead to optimal and evidence-based thiopurine and methotrexate treatment strategies in IBD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据